NORBERT G RIEDEL
CIK 1161662 · EXECUTIVE CHAIRMAN OF THE BOD · last filed 2026-04-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.13M
Companies
8
Total Filings
77
Lifetime Open-Market Net
-$28.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ETON | Director | 224,300 | $31.59 | $7.09M | $30.0K | 12 | 2026-04-22 |
| JAZZ | Director | 21,069 | $230.56 | $4.86M | -$3.30M | 18 | 2026-03-02 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 56,553 | $44.96 | $2.54M | $0 | 4 | 2024-06-07 |
| Aptinyx Inc. (APTX) Delisted | EXECUTIVE CHAIRMAN OF THE BOD | 650,265 | $0.06 | $39.7K | $366.4K | 13 | 2023-01-05 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | 28,540 | $18.07 | $515.7K | $0 | 2 | 2021-06-14 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Director | 0 | — | — | $0 | 8 | 2017-02-16 |
| BAX | Corporate Vice President | 56,689 | $20.86 | $1.18M | -$25.15M | 17 | 2013-01-18 |
| OSCIENT PHARMACEUTICALS CORP (OSCI) Delisted | Director | 1,340 | — | — | $0 | 2 | 2008-06-13 |
Recent Filings · Page 7 of 8
77 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-05-02 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2011-03-08 | BAX | Grant (A) | — | $0 | EDGAR |
| 2011-01-21 | BAX | Mixed | +2,206 | -$55.1K | EDGAR |
| 2010-03-17 | BAX | Tax (F) | −763 | -$44.5K | EDGAR |
| 2010-03-09 | BAX | Mixed | — | -$737.1K | EDGAR |
| 2010-03-05 | BAX | Grant (A) | — | $0 | EDGAR |
| 2010-01-22 | BAX | Mixed | +13,677 | -$384.4K | EDGAR |
| 2009-12-04 | BAX | Mixed | — | -$2.03M | EDGAR |
| 2009-03-18 | BAX | Tax (F) | −2,105 | -$107.5K | EDGAR |
| 2009-03-06 | BAX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.